BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 604113)

  • 1. IgM and IgG antibody responses following immunization of children and adults with influenza A/NJ/76 vaccines.
    Boyer KM; Cherry JD; Noble GR
    Dev Biol Stand; 1977 Jun 1-3; 39():303-8. PubMed ID: 604113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgM and IgG antibody responses after immunization of children with inactivated monovalent (A/New Jersey/76) and bivalent (A/New Jersey/76-A/Victoria/75) influenza virus vaccines.
    Boyer KM; Cherry JD; Welliver RC; Dudley JP; Deseda-Tous J; Zahradnik JM; Krause PJ; Spencer MJ; Bryson YJ; Garakian AJ
    J Infect Dis; 1977 Dec; 136 Suppl():S665-71. PubMed ID: 342632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influenza immunization in children and young adults: clinical reactions and total and IgM antibody responses after immunization with whole-virus or split-product influenza vaccines.
    Bernstein DI; Zahradnik JM; DeAngelis CJ; Cherry JD
    Am J Dis Child; 1982 Jun; 136(6):513-7. PubMed ID: 7046421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Local and systemic antibody response after vaccination with 3 different types of vaccines against influenza I. Hemagglutinationinhibiting antibodies (author's transl)].
    Kuwert EK; Werner J; Scheiermann N; Pledt T
    Zentralbl Bakteriol Orig A; 1979 Jul; 244(2-3):155-74. PubMed ID: 506543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiation of the immune response to influenza virus subunit vaccines.
    Webster RG; Glezen WP; Kasel JA; Laver WG
    Dev Biol Stand; 1977 Jun 1-3; 39():243-8. PubMed ID: 604104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experience with monovalent and bivalent influenza vaccines in Canada 1976. Clinical evaluation of vaccines from four sources.
    Johnson SE; Pearson EW
    Dev Biol Stand; 1977 Jun 1-3; 39():267-72. PubMed ID: 342309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical trials with a new influenza subunit vaccine in adults and children.
    Kunz C; Hofmann H; Bachmayer H; Liehl E; Moritz AJ
    Dev Biol Stand; 1977 Jun 1-3; 39():297-302. PubMed ID: 342311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serological responses to whole and split A/New Jersey vaccines in humans and mice following priming infection with influenza A viruses.
    Ennis FA; Wise TG; McLaren C; Verbonitz MW
    Dev Biol Stand; 1977 Jun 1-3; 39():261-6. PubMed ID: 604108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Live tissue culture influenza vaccine for oral administration. I. Specific immune response to monovaccine A (H3N2) in volunteers.
    Alekseeva AK; Andzhaparidze OG; Gracheva EN; Sidorova LA; Melnikova SK
    Acta Virol; 1979 Jan; 23(1):59-66. PubMed ID: 35960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody response to anti-A/New Jersey/76 vaccines.
    Hannoun C; Barme M; Sérié C; Beck H; Aquino J; Thibon M
    Dev Biol Stand; 1977 Jun 1-3; 39():249-52. PubMed ID: 604105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization against human and swine-like influenza A: serological response to two inactivated vaccines of different formulation.
    Cuneo-Crovari P; Giacometti G; Gasparini R; Fontana G
    Boll Ist Sieroter Milan; 1976; 55(5):371-8. PubMed ID: 1016590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
    Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison between killed subunit influenza vaccines and whole virion preparations: study of reactions and protective efficacy in children and adults].
    Profeta ML; Bigatello A; Vacchini V; Bramati L; Ferrante P
    Boll Ist Sieroter Milan; 1980 Jan; 58(6):457-74. PubMed ID: 6778485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humoral and cellular immune responses in children given annual immunization with trivalent inactivated influenza vaccine.
    Zeman AM; Holmes TH; Stamatis S; Tu W; He XS; Bouvier N; Kemble G; Greenberg HB; Lewis DB; Arvin AM; Dekker CL
    Pediatr Infect Dis J; 2007 Feb; 26(2):107-15. PubMed ID: 17259871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization with a DNA chimeric molecule encoding a hemagglutinin peptide and a scFv CD21-specific antibody fragment induces long-lasting IgM and CTL responses to influenza virus.
    Ivanovska N; Tchorbanov A; Prechl J; Maximova V; Voynova E; Vassilev TL
    Vaccine; 2006 Mar; 24(11):1830-7. PubMed ID: 16289708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum and mucosal immunologic responses in children following the administration of a new inactivated intranasal anti-influenza vaccine.
    Greenbaum E; Furst A; Kiderman A; Stewart B; Levy R; Schlesinger M; Morag A; Zakay-Rones Z
    J Med Virol; 2001 Sep; 65(1):178-84. PubMed ID: 11505461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune response after influenza vaccination in children with cancer.
    Matsuzaki A; Suminoe A; Koga Y; Kinukawa N; Kusuhara K; Hara T
    Pediatr Blood Cancer; 2005 Nov; 45(6):831-7. PubMed ID: 16007602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of age and natural priming on the IgG and IgA subclass responses after parenteral influenza vaccination.
    El-Madhun AS; Cox RJ; Haaheim LR
    J Infect Dis; 1999 Oct; 180(4):1356-60. PubMed ID: 10479172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Head-to-head comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines: effect of composition, spatial organization and immunization route on the immunogenicity in a murine challenge model.
    Hagenaars N; Mastrobattista E; Glansbeek H; Heldens J; van den Bosch H; Schijns V; Betbeder D; Vromans H; Jiskoot W
    Vaccine; 2008 Dec; 26(51):6555-63. PubMed ID: 18848856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody response in humans after administration of whole-virion and split vaccine prepared from two different influenza A/swine viruses.
    Závadová H; Vonka V; Domorázková E; Syrůcek L; Stárek M; Hrusková J; Plesník V; Janout V; Uvízl M
    Dev Biol Stand; 1977 Jun 1-3; 39():231-4. PubMed ID: 604101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.